Position in NVS
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$57,281
+$5,580 QoQ
Shares Held
375
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026McIlrath & Eck, LLC holds $2,576,783 across 13 Drug Manufacturers - General names. NVS ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
855 | $786,403 | |
| 2 | AMGN |
Amgen Inc
|
1,870 | $657,959 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,198 | $264,397 | |
| 4 | ABBV |
AbbVie Inc.
|
1,138 | $247,503 | |
| 5 | PFE |
Pfizer Inc
|
6,155 | $172,832 | |
| 6 | JNJ |
Johnson & Johnson
|
594 | $145,197 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,324 | $140,950 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
585 | $81,531 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,281 | 375 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $51,701 | 375 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $48,090 | 375 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $45,378 | 375 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $41,805 | 375 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $36,491 | 375 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $43,132 | 375 | Shares | Sole | 2024-11-19 | |
| 2024-06-30 | $39,922 | 375 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,273 | 375 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $37,863 | 375 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $38,197 | 375 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $27,750 | 275 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $88,412 | 961 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $85,730 | 945 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $71,829 | 945 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $79,880 | 945 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $82,923 | 945 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $82,659 | 945 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $77,282 | 945 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $39,141 | 429 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $36,670 | 429 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $35,411 | 375 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $32,610 | 375 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $37,119 | 425 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $33,557 | 407 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||